In summary, this study presents an innovative biodiagnostic platform, PRADA, demonstrating multiplexed detection of two biomarkers of myocardial infarction, cTnI and NPY, in a simple microfluidic device. This evidence concerns the gene TNNI3 and myocardial infarction.